These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 15897906
1. HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. Singh TR, Shankar S, Srivastava RK. Oncogene; 2005 Jul 07; 24(29):4609-23. PubMed ID: 15897906 [Abstract] [Full Text] [Related]
2. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK. Int J Mol Med; 2005 Dec 07; 16(6):1125-38. PubMed ID: 16273296 [Abstract] [Full Text] [Related]
3. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T. Oncogene; 2004 Aug 19; 23(37):6261-71. PubMed ID: 15208660 [Abstract] [Full Text] [Related]
4. Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells. Earel JK, VanOosten RL, Griffith TS. Cancer Res; 2006 Jan 01; 66(1):499-507. PubMed ID: 16397266 [Abstract] [Full Text] [Related]
10. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Shankar S, Srivastava RK. Drug Resist Updat; 2004 Apr 01; 7(2):139-56. PubMed ID: 15158769 [Abstract] [Full Text] [Related]
13. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M. Hepatology; 2006 Mar 01; 43(3):425-34. PubMed ID: 16583461 [Abstract] [Full Text] [Related]
14. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC. Cancer Res; 2005 Jun 01; 65(11):4799-808. PubMed ID: 15930300 [Abstract] [Full Text] [Related]